绝经后妇女冠状动脉样性心脏病的危险因素:一个元分析
Xin Miao1,2, Lixing Wu3, Kuiyue Wang4
1Department of Nursing, School of Medical and Health Engineering, Changzhou University, Changzhou, Jiangsu, China.
Frontiers in cardiovascular medicine
|January 28, 2025
概括
在绝经后的妇女中,有六次或更多的怀孕史显著增加了冠状动脉心脏病 (CHD) 的风险. 这一发现突出了预防心血管疾病的关键因素.
科学领域:
- 心血管医学 心血管医学
- 流行病学 流行病学
- 妇女健康 妇女健康
背景情况:
- 冠心病 (CHD) 是全球女性的主要死亡原因,发病率不断增加.
- 绝经后雌激素的下降会增加女性心血管疾病的风险.
- 绝经后妇女心脏病的危险因素需要进一步澄清.
研究的目的:
- 系统地评估冠状动脉心脏病 (CHD) 的风险因素,特别是绝经后妇女.
- 确定这一群体中心血管疾病发病率和死亡率的关键预测因素.
主要方法:
- 在多个数据库 (PubMed,Embase,Web of Science等) 进行全面的文献搜索. 在2024年2月之前.
- 两个研究人员独立提取数据并进行质量评估.
- 使用STATA17.0软件进行元分析,综合包括的研究结果.
主要成果:
- 包含294,103名患者的9项研究被纳入了元分析.
- 六次或以上的怀孕史与心脏病风险增加有显著的关联 (HR=1.538,95% CI:1.241%-1.906%,P <0.05).
结论:
- 多胎妊娠是绝经后妇女冠心病 (CHD) 发病率和死亡率的重要危险因素.
- 需要进一步进行高质量的研究来验证这些发现,并为临床实践提供信息.
相关概念视频
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations
620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


